Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using mTOR Inhibitors in the Prevention of BK Nephropathy

NCT01649609 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01649609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01649609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using mTOR Inhibitors in the Prevention of BK Nephropathy
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2012
Completion date
December 31, 2016
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bk nephropathy, bk viremia